US 8524906
Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8524906 (Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/18, A61P11/00